医学
视神经脊髓炎
生物标志物
髓鞘少突胶质细胞糖蛋白
精密医学
视神经
生物标志物发现
光谱紊乱
多发性硬化
抗体
临床神经学
磁共振成像
医学影像学
病理
视神经炎
药品
免疫疗法
治疗药物监测
出处
期刊:PubMed
[National Institutes of Health]
日期:2026-07-11
卷期号:62 (7): 549-556
标识
DOI:10.3760/cma.j.cn112142-20260325-00120
摘要
, significant progress has been achieved in the diagnostic classification, biomarker detection and targeted therapy of optic neuritis. A quantitative evaluation system combining multimodal imaging and serological antibody testing has been established for clinical application. The updated McDonald criteria have incorporated the optic nerve into the lesion localization of multiple sclerosis. Detection of aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies serves as a key tool for the definitive diagnosis of neuromyelitis optica spectrum disorder and MOG antibody-associated disease. Plasma exchange can improve the prognosis of severe cases, and biological agents represent the first-line therapeutic strategy for AQP4-positive patients. Considering the current domestic status of antibody detection capabilities and drug accessibility, this article proposes implementing routine antibody screening at initial diagnosis, optimizing multidisciplinary collaboration models, and constructing a real-world clinical data system.
科研通智能强力驱动
Strongly Powered by AbleSci AI